β-catenin and E-cadherin in Colorectal Cancer
Author Information
Author(s): Garinis G A, Spanakis N E, Menounos P G, Manolis E N, Peros G
Primary Institution: Nursing Military Academy, Laboratory of Research, Athens, Greece
Hypothesis
Is there an association between β-catenin mutations and the transcriptional activity of the β-catenin/E-cadherin complex in colorectal carcinomas?
Conclusion
The study found that β-catenin mutations are infrequent in sporadic colorectal carcinomas and do not account for the loss of β-catenin/E-cadherin transcriptional activity.
Supporting Evidence
- 65% of the carcinomas examined showed decreased β-catenin mRNA expression.
- 68% of the carcinomas showed decreased E-cadherin mRNA expression.
- Decreased E-cadherin IHC expression was observed in 57% of SCRCs.
Takeaway
This study looked at how a protein called β-catenin behaves in colorectal cancer and found that changes in its gene are rare, suggesting other factors might be causing problems with cell adhesion.
Methodology
The study analyzed tumor tissues from 63 colorectal adenocarcinomas using PCR and immunohistochemistry to assess β-catenin and E-cadherin expression.
Limitations
The study was limited by the sample size and the focus on a specific subset of colorectal carcinomas.
Participant Demographics
The subset of 37 patients included 20 males and 17 females with a mean age of 67.3 years.
Statistical Information
P-Value
P=0.001
Statistical Significance
p<0.03
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website